Illumina files for patent infringement over prenatal test

Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Illumina accused of fraud in DNA tech patents dispute

12 January 2021 Illumina tried to secure its control over the DNA sequencing technology market by violating antitrust law, according to a suit by BGI Americas and two of its subsidiaries, at the US Court for the District Court of San Francisco.

Europe

Prenatal test infringes Illumina patents, rules English High Court

22 November 2017 A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.

Americas

Illumina to pay Enzo $21m to end patent dispute

14 July 2016 Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.

More on this story

Americas

Illumina accused of fraud in DNA tech patents dispute

Europe

Prenatal test infringes Illumina patents, rules English High Court

22 November 2017 A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.

Americas

Illumina to pay Enzo $21m to end patent dispute

14 July 2016 Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.

More on this story

Americas

Illumina accused of fraud in DNA tech patents dispute

Europe

Prenatal test infringes Illumina patents, rules English High Court

22 November 2017 A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.

Americas

Illumina to pay Enzo $21m to end patent dispute

14 July 2016 Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.